Skip to main content
Log in

Hartnup syndrome, progressive encephalopathy and allo-albuminaemia

A clinico-pathological case study

  • Metabolic Diseases
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Clinical, biochemical, neuropathological and neurochemical findings in a case of Hartnup syndrome are reported. After initially normal development, the affected girl suffered progressive neuropsychiatric decline with statomotor and mental retardation and intractable seizures and died at the age of 2 years. Postmortem neuropathological and neurochemical investigations showed a combination of extensive neuronal degeneration and cerebral dysmyelination. Pathogenetic hypotheses and the relationship between neuropsychiatric disease and Hartnup syndrome are discussed. Additionally, a fast type bisalbuminaemia present in the girl and her mother is described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arai K, Ishioka N, Huss K, Madison J, Putnam FW (1989) Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci USA 86:434–438

    PubMed  Google Scholar 

  2. Daute KH, Dietel K, Ebert W (1966) Das Hartnup-Syndrom. Bericht über einen tödlichen Krankheitsverlauf. Z. Kinderheilkd 95:103–113

    Article  PubMed  Google Scholar 

  3. Denkla WD, Dewey HK (1967) The determination of tryptophan in plasma, liver and urine. J Lab Clin Med 69:160–169

    PubMed  Google Scholar 

  4. Fine JM, Marneux M, Rochu D (1987) Human albumin genetic variants: an attempt at a classification of European allotypes. Am J Hum Genet 40:278–286

    PubMed  Google Scholar 

  5. Halvorsen K, Halvorsen S (1961) Hartnup disease. Proc 13th North Pediatr Congr 1961:119–120

    Google Scholar 

  6. Halvorsen K, Halvorsen S (1963) Hartnup disease Pediatrics 31:29–38

    Google Scholar 

  7. Herschkowitz N, McKann GM, Sooter EM (1968) Studies of water soluble lipoprotein in rat brain. J Neurochem 15:161–168

    PubMed  Google Scholar 

  8. Jepson JB (1978) Hartnup disease. In: Stanbury J, Wyngaarden JB, Fredrickson DS (eds). The metabolic basis of inherited disease, 4th edn. McGraw Hill, New York, 1563–1577

    Google Scholar 

  9. Kullmann K-H, Endres W, Krizinger S, Schmidt H-L (1982) Direkte Bestimmung von Phenylanalin in Serum mittels Derivativspektrophotometrie. J Clin Chem Clin Biochem 20:181–183

    PubMed  Google Scholar 

  10. Levy HL (1989) Hartnup disorder. In: Stanbury J, Wyngaarden JB, Fredrickson DS (eds) the metabolic basis of inherited disease, 5th edn. McGraw Hill, New York, 2515–2527

    Google Scholar 

  11. Milne MD (1969) Hartnup disease. Biochem J 11:3–4

    Google Scholar 

  12. Milne MD, Crawford MA, Girao CB, Loughridge IW (1960) The metabolic disorder in Hartnup disease. Q J Med 115:407–421

    Google Scholar 

  13. Nutrition Reviews (1984) 42 (7):251–253

  14. Oyanagi K, Takagi M, Kitabatake M, Nakao T (1967) Hartnup disease. Tohoku J Exp Med 91:383–395

    PubMed  Google Scholar 

  15. Parvy P, Huang Y, Kamoun P (1979) Age related reference values for urinary free amino acids: A simple method of evaluation. J Clin Chem Clin Biochem 17:205–210

    PubMed  Google Scholar 

  16. Pentschew A (1958) Mangelzustände. In: Scholz W (ed) Handbuch der speziellen pathologischen Anatomie und Histologie, Nervensystem (Vol. 13/II). Springer. Berlin Heidelberg New York, pp 2503–2570

    Google Scholar 

  17. Peters JH, Lin SC, Berridge BJ Jr, Cummings JG, Chao WR (1969) Amino acids, including asparagine and glutamine, in plasma and urine of normal human subjects. Proc. Soc Exp Biol Med 131:281–288

    PubMed  Google Scholar 

  18. Prensky AL, Nelson JS, Tahmouch AJ (1978) Note on Hartnup disease. Adv Neurol 21:339–343

    PubMed  Google Scholar 

  19. Scriver CR, Mahon B, Levy HL, Clow CL, Reade TM, Kronick J, Lemieux B, Laberge C (1987) The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. Am J Hum Genet 40 (5):401–412

    PubMed  Google Scholar 

  20. Siegrist HP, Burkhart T, Steck AJ, Wiesmann U, Herschkowitz NN (1976) Influence of lipids on the activity of cerebroside-sulfotransferase in mouse brain: a comparative study of jimpy and normal mouse brains. J Neurochem 27:599–604

    PubMed  Google Scholar 

  21. Sogin DC (1976) 2′,3′-cyclic nucleotide 3′-cyclic nucleotide 3′-phosphohydrolase. J Neurochem 27:1333–1337

    PubMed  Google Scholar 

  22. Tahmoush AJ, Alpers DH, Feigin RD, Armbrustmacher V, Prensky AL (1976) Hartnup disease. Clinical, pathological and biochemical observations. Arch Neurol 33:797–807

    PubMed  Google Scholar 

  23. Visakorpi JK, Hjelt L, Lahikainen T, Öhman S (1964) Hartnup disease in two siblings. Clinical observations and biochemical studies. Ann Paediatr Fenn 10:42–56

    PubMed  Google Scholar 

  24. Wong PWK, Lambert AM, Pillai PM, Jones PM (1967) Observations on nicotinic acid therapy in hartnup disease. Arch Dis Child 42:642b

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidtke, K., Endres, W., Roscher, A. et al. Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. Eur J Pediatr 151, 899–903 (1992). https://doi.org/10.1007/BF01954126

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01954126

Key words

Navigation